http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004242863-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-14 |
filingDate | 2003-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c057837453fd70ed5f8e227eb9c2ea7 |
publicationDate | 2004-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2004242863-A1 |
titleOfInvention | Preparation of cefalosporins intermediates and conversion of said intermediates into active compound precursors |
abstract | There is described the preparation of the new 7β-[(2-aminothiazol-4-yl)glyoxylamido-3-hydroxymethyl-2-cephem-4-carboxylic acid derivatives, in which the amino group is free or protected by a removable group, and the subsequent conversion of the compounds thus obtained into active cephalosporin precursors either by esterification of the hydroxy group or replacement of the hydroxy group by a halogen atom and, in the latter case, by subsequent replacement of the halogen atom of said 7β-[(2-aminothiazol-4-yl)glyoxylamido-3-halomethyl-3-cephem-4-carboxylic acid derivatives by the residue of a nucleophilic compound to obtain corresponding, immediate precursors of 7β-[α-(2-aminothiazol-4-yl-α-methoxyimino]acetamido-3-(substituted)methyl-3-cephem-4-carboxylic acid derivatives. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105418641-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105418641-A |
priorityDate | 2003-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 538.